Sorting by

×

Pharmaceutical sector surges 0.66% in a sluggish stock market

Image

The Nifty Pharma Index Shows Positive TradingCopy

The Nifty Pharma index traded positively in a weak market on Thursday. Among the top gainers were Granules India Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Divi’s Laboratories Ltd., and Torrent Pharmaceuticals Ltd.

Top Losers on the IndexCopy

Cipla Ltd., Ipca Laboratories Ltd., Sanofi India Ltd., and Gland Pharma Ltd. were the top losers on the index.

Subscribe to our Social Media for Exclusive Crypto News and Insights 24/7!

Current Status of the Nifty Pharma IndexCopy

At the time of writing this report, the Nifty Pharma index was up 0.66% at 16095.7. The benchmark NSE Nifty50 index was down 34.05 points at 20062.55, while the BSE Sensex was down 150.83 points at 66751.08.

Market PerformanceCopy

Out of the 50 stocks in the Nifty index, 25 were trading in the green, while 25 were in the red.

Most Traded Shares on the NSECopy

The most traded shares on the NSE included Indian Renewable, YES Bank, Reliance Power, JP Power, and Vodafone Idea.

52-Week Highs and LowsCopy

In today’s trade, shares of Global Education, Shradha Infraproject, New India Assurance, Indian Renewable, and Navkar Corp hit their fresh 52-week highs. On the other hand, Aether Industries, Fourth Dimension Sol, Raj Rayon, Winsome Yarns, and Blue Jet Healthcare hit fresh 52-week lows.

Hot Take: The Nifty Pharma Index Holds Strong Amidst Market WeaknessCopy

The Nifty Pharma index has displayed resilience by trading positively in a weak market. This indicates the strength and potential of the pharmaceutical sector. Despite the overall decline in the market, several pharma companies have shown significant gains, while others have experienced minor losses. This demonstrates the diversity and volatility of the sector. Investors should closely monitor the performance of individual pharmaceutical stocks to make informed investment decisions.

Read Disclaimer
This content is aimed at sharing knowledge, it's not a direct proposal to transact, nor a prompt to engage in offers. Lolacoin.org doesn't provide expert advice regarding finance, tax, or legal matters. Caveat emptor applies when you utilize any products, services, or materials described in this post. In every interpretation of the law, either directly or by virtue of any negligence, neither our team nor the poster bears responsibility for any detriment or loss resulting. Dive into the details on Critical Disclaimers and Risk Disclosures.

Share it

Source

Pharmaceutical sector surges 0.66% in a sluggish stock market